Sitalembic D 10mg/100mg Tablet
By Sitalembic D
Rx
15 Tablet in a Strip

Composition
Dapagliflozin(10mg) + Sitagliptin(100mg)

Manufacturer - Alembic Pharmaceuticals Ltd
Alembic Road, Vadodara - 390 003, Gujarat,INDIA

Expires on or after
July, 2026
About Sitalembic D 10mg/100mg Tablet
Sitalembic D 10mg/100mg Tablet is a combination medication used to manage blood sugar levels in adults with type 2 diabetes mellitus. It works by aiding in the proper utilization of insulin, which helps lower blood sugar levels. It is important to take this medicine as prescribed by your doctor and to not discontinue its use without consulting them, as abrupt discontinuation can lead to an increase in blood sugar levels and serious complications such as kidney damage and blindness.
You can take Sitalembic D 10mg/100mg Tablet with or without food at any time of the day, but it is recommended to take it at the same time daily for better effectiveness. Along with medication, a treatment program for type 2 diabetes should include a healthy diet, regular exercise, and weight management as advised by your healthcare provider.
Common side effects of Sitalembic D 10mg/100mg Tablet may include urinary tract infections, nasal congestion, sore throat, and upper respiratory tract infections. Staying hydrated by drinking plenty of fluids can help prevent dehydration, while practicing good hygiene can reduce the risk of fungal infections in the genital area. It is essential to inform your doctor about any existing kidney or liver issues, urinary tract infections, or the use of diuretics before starting this medication. Pregnant or breastfeeding women should also consult their doctor before taking Sitalembic D 10mg/100mg Tablet, and excessive alcohol consumption should be avoided as it may increase the risk of side effects.
Sitalembic D 10mg/100mg Tablet contains two active ingredients - Dapagliflozin and Sitagliptin. Dapagliflozin helps lower blood glucose levels and increase glucose excretion in the urine, while Sitagliptin works by increasing insulin levels and decreasing glucagon levels to reduce glucose production in the liver. This combination helps control blood sugar levels in individuals with type 2 diabetes mellitus.
If you experience side effects such as diarrhea, hypoglycemia, headache, nausea, or vomiting while taking Sitalembic D Tablet 15's, they are usually mild and tend to resolve over time. However, it is important to inform your doctor if these effects persist or become bothersome. It is advisable to take Sitalembic D Tablet 15's exactly as prescribed by your doctor to ensure optimal effectiveness and safety.
Before starting Sitalembic D Tablet 15's, inform your healthcare provider if you are allergic to any of its components, pregnant, breastfeeding, or taking any other medications. Providing a comprehensive overview of your health condition will help in preventing any potential adverse effects or interactions with this medication. Regular monitoring of blood sugar levels is recommended while using Sitalembic D Tablet 15's to ensure effective management of type 2 diabetes mellitus.
Disclaimer
The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.
₹251.8
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 07-Oct-2024
